Cassava Sciences | PTIE - Pasivo Circulante

Precio De Mercado
1.61
Cambio Diario
-0.05 -3.01%
Mensual
-12.02%
Anual
2.55%
Q2 Expectativa
1.58




Pasivo Circulante Cambio Fecha
Abbott USD 16.5B 1.91B 2025-12
Amgen USD 25.49B 3.7B 2025-12
Biogen USD 3.35B 59.4M 2025-12
Cara Therapeutics USD 11.04M 362K 2025-09
Cassava Sciences USD 43.83M 4.21M 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Geron USD 113.82M 26.11M 2025-12
J&J USD 57.72B 3.59B 2026-03
Merck USD 28.63B 2.59B 2025-09
Novartis USD 27.28B 4.72B 2025-12
Novavax USD 459.95M 30.08M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Roche Holding CHF 28B 421M 2025-12